Bausch Health Files 8-K on Security Holder Votes
Ticker: BHC · Form: 8-K · Filed: May 15, 2024 · CIK: 885590
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Bausch Health had a shareholder vote on 5/15/24. Details TBD.
AI Summary
Bausch Health Companies Inc. filed an 8-K on May 15, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or outcomes, but it serves as an official notification of such events.
Why It Matters
This filing indicates that Bausch Health has held or is holding a meeting where shareholders are voting on important company matters, which could impact corporate governance and future decisions.
Risk Assessment
Risk Level: low — This is a routine filing to report on shareholder votes, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 20240515 — Filing Date (Date of report and earliest event)
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- 2150 St. Elzéar Blvd. West (location) — Principal Executive Offices
- Laval, Québec (location) — City and Province of Principal Executive Offices
FAQ
What specific matters were submitted for a vote by Bausch Health's security holders?
The filing does not specify the exact matters voted upon, only that such matters were submitted.
When did the event related to the security holder vote occur?
The earliest event reported is dated May 15, 2024.
What is the principal executive office address for Bausch Health Companies Inc.?
The principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
What is the IRS Employer Identification Number for Bausch Health Companies Inc.?
The IRS Employer Identification Number is 98-0448205.
What was Bausch Health Companies Inc. formerly known as?
The company was formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp.
Filing Stats: 706 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-15 08:07:09
Filing Documents
- bhc-20240515.htm (8-K) — 47KB
- 0000885590-24-000021.txt ( ) — 173KB
- bhc-20240515.xsd (EX-101.SCH) — 2KB
- bhc-20240515_lab.xml (EX-101.LAB) — 22KB
- bhc-20240515_pre.xml (EX-101.PRE) — 13KB
- bhc-20240515_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On May 14, 2024, Bausch Health Companies Inc. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). At the Annual Meeting, the shareholders of the Company voted on the following four proposals, each of which is described in detail in the Company's Management Proxy Circular and Proxy Statement. The results of each matter voted upon are as follows: Proposal No. 1: Election of Directors. The shareholders elected the following individuals to the Company's Board of Directors, to serve until the close of the Company's 2025 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director's earlier resignation or removal: Name For Withheld Broker Non-Votes Thomas J. Appio 181,373,219 10,918,741 70,931,303 Christian A. Garcia 181,143,285 11,148,675 70,931,303 Brett M. Icahn 170,144,670 22,147,290 70,931,303 Sarah B. Kavanagh 180,316,464 11,975,496 70,931,303 Frank D. Lee 173,147,642 19,144,318 70,931,303 Steven D. Miller 177,700,669 14,591,291 70,931,303 Richard C. Mulligan, Ph.D. 175,256,854 17,035,106 70,931,303 John A. Paulson 179,422,691 12,869,269 70,931,303 Robert N. Power 173,228,670 19,063,290 70,931,303 Amy B. Wechsler, M.D. 181,626,477 10,665,483 70,931,303 Proposal No. 2: Advisory Vote on Executive Compensation. The shareholders approved, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Management Proxy Circular and Proxy Statement. For Against Abstain Broker Non-Votes I 78,660,733 5,195,531 8,435,696 70,931,303 Proposal No. 3: Approval of an Amendment to the Company's 2014 Ominbus Incentive Plan. The shareholders approved the amendment to the Company's 2014 Omnibus Incentive Plan (the " 2014 Plan ") to increase the number of Common
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 15, 2024 BAUSCH HEALTH COMPANIES INC. By: /s/ Seana Carson Seana Carson Executive Vice President, General Counsel